Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar T Overton

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2022
Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)Kara W Chew, Kunling Wu, Katherine Tassiopoulos, et al.
Kidney International Reports|April 14, 2025
<i>APOL1</i> Genotype and HIV Infection: 20-Year Outcomes for CKD, Cardiovascular Disease, and HypertensionKatherine K Tassiopoulos, Kunling Wu, Zhenzhen Wu, et al.
Journal of the American Society of Hypertension : JASH|June 19, 2017
Race and sex differences in ambulatory blood pressure measures among HIV+ adultsShia T Kent, Joseph E Schwartz, Daichi Shimbo, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsRoger Bedimo, Minhee Kang, Pablo Tebas, et al.
Journal of Clinical Pharmacology|February 12, 2010
The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapyEdgar T Overton, Jean M Tschampa, Michael Klebert, et al.
Kidney International Reports|July 26, 2021
Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis PopulationArun Rajasekaran, Ricardo A Franco, Edgar T Overton, et al.
AIDS Research and Human Retroviruses|May 14, 2016
Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011Pragna Patel, Timothy Bush, E Milu Kojic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and InflammationMichael P Dubé, Lauren Komarow, Carl J Fichtenbaum, et al.
AIDS (London, England)|August 11, 2022
Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment eraGabriel Spieler, Andrew O Westfall, Dustin M Long, et al.
AIDS (London, England)|August 18, 2022
Obesity in HIV infection: host-pathogen interactionStefano Savinelli, Neil E Wrigley Kelly, Eoin R Feeney, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2022
Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)Kara W Chew, Kunling Wu, Katherine Tassiopoulos, et al.
Kidney International Reports|April 14, 2025
<i>APOL1</i> Genotype and HIV Infection: 20-Year Outcomes for CKD, Cardiovascular Disease, and HypertensionKatherine K Tassiopoulos, Kunling Wu, Zhenzhen Wu, et al.
Journal of the American Society of Hypertension : JASH|June 19, 2017
Race and sex differences in ambulatory blood pressure measures among HIV+ adultsShia T Kent, Joseph E Schwartz, Daichi Shimbo, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsRoger Bedimo, Minhee Kang, Pablo Tebas, et al.
Journal of Clinical Pharmacology|February 12, 2010
The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapyEdgar T Overton, Jean M Tschampa, Michael Klebert, et al.
Kidney International Reports|July 26, 2021
Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis PopulationArun Rajasekaran, Ricardo A Franco, Edgar T Overton, et al.
AIDS Research and Human Retroviruses|May 14, 2016
Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011Pragna Patel, Timothy Bush, E Milu Kojic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2015
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and InflammationMichael P Dubé, Lauren Komarow, Carl J Fichtenbaum, et al.
AIDS (London, England)|August 11, 2022
Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment eraGabriel Spieler, Andrew O Westfall, Dustin M Long, et al.
AIDS (London, England)|August 18, 2022
Obesity in HIV infection: host-pathogen interactionStefano Savinelli, Neil E Wrigley Kelly, Eoin R Feeney, et al.
Pageof 10